The stock of Dogwood Therapeutics Inc (DWTX) has seen a -7.27% decrease in the past week, with a -14.76% drop in the past month, and a 123.36% flourish in the past quarter. The volatility ratio for the week is 42.13%, and the volatility levels for the past 30 days are at 23.48% for DWTX. The simple moving average for the last 20 days is 0.27% for DWTX’s stock, with a simple moving average of 20.23% for the last 200 days.
Is It Worth Investing in Dogwood Therapeutics Inc (NASDAQ: DWTX) Right Now?
The 36-month beta value for DWTX is at 1.55. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for DWTX is 1.05M, and currently, shorts hold a 2.51% of that float. The average trading volume for DWTX on March 17, 2025 was 3.69M shares.
DWTX) stock’s latest price update
Dogwood Therapeutics Inc (NASDAQ: DWTX)’s stock price has dropped by -20.83 in relation to previous closing price of 7.73. Nevertheless, the company has seen a loss of -7.27% in its stock price over the last five trading days. globenewswire.com reported 2025-01-21 that ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on advancing first-in class, non-opioid, Nav 1.7 inhibitor treatments for chronic and acute pain, announced today that dosing of the first patient in its Phase 2b clinical trial, referred to as HALT-CINP (Halneuron® Treatment of Chemotherapy Induced Neuropathic Pain), evaluating Halneuron® to treat neuropathic pain associated with prior chemotherapy treatment (“CINP”) is expected to occur in the first quarter of 2025.
DWTX Trading at -10.71% from the 50-Day Moving Average
After a stumble in the market that brought DWTX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.10% of loss for the given period.
Volatility was left at 23.48%, however, over the last 30 days, the volatility rate increased by 42.13%, as shares sank -8.79% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +114.74% upper at present.
During the last 5 trading sessions, DWTX fell by -7.27%, which changed the moving average for the period of 200-days by +16.91% in comparison to the 20-day moving average, which settled at $6.10. In addition, Dogwood Therapeutics Inc saw 145.78% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for DWTX
Equity return is now at value -200.48, with -152.02 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.71.
Conclusion
In conclusion, Dogwood Therapeutics Inc (DWTX) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
